Standout Papers
- Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial (2009)
- Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial (2014)
Immediate Impact
3 by Nobel laureates 4 from Science/Nature 68 standout
Citing Papers
Thyroid Cancer
2024 Standout
Cancer statistics, 2023
2023 Standout
Works of Carol Peña being referenced
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
2014 Standout
Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
2009 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Carol Peña | 867 | 757 | 485 | 898 | 872 | 9 | 2.3k | |
| Annetta Krebs | 1849 | 1941 | 392 | 709 | 405 | 8 | 2.7k | |
| Frauke Bentzien | 510 | 657 | 296 | 805 | 241 | 12 | 2.0k | |
| Cristiana Lupi | 611 | 1628 | 363 | 694 | 1129 | 34 | 2.7k | |
| Katherine Liau | 833 | 1082 | 436 | 858 | 382 | 36 | 2.0k | |
| Ronak Shah | 295 | 759 | 406 | 681 | 653 | 23 | 1.8k | |
| Josef Brueggen | 342 | 620 | 378 | 1819 | 252 | 14 | 2.4k | |
| Jong-Yeon Shin | 619 | 564 | 518 | 945 | 354 | 25 | 1.8k | |
| Alex Smith | 1032 | 585 | 397 | 626 | 289 | 21 | 2.1k | |
| Joseph T. Spaulding | 1502 | 454 | 256 | 406 | 412 | 21 | 2.2k | |
| Mária Dudás | 805 | 643 | 490 | 791 | 201 | 21 | 2.0k |
All Works
Loading papers...